Driehaus Capital Management LLC Exagen Inc. Transaction History
Driehaus Capital Management LLC
- $10.3 Billion
- Q4 2024
A detailed history of Driehaus Capital Management LLC transactions in Exagen Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 418,505 shares of XGN stock, worth $1.77 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
418,505Holding current value
$1.77 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding XGN
# of Institutions
43Shares Held
6.06MCall Options Held
4.5KPut Options Held
400-
Rtw Investments, LP New York, NY1.51MShares$6.4 Million0.1% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$3.77 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY535KShares$2.26 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.08 Million0.0% of portfolio
-
Morgan Stanley New York, NY484KShares$2.05 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $68.8M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...